Change in Leadership at DIREVO Industrial Biotechnology GmbH

05-May-2010 - Germany

DIREVO Industrial Biotechnology GmbH announced that effective May 1st Dr. Jorg Riesmeier was promoted to Chief Executive Officer. Dr. Riesmeier who joined on January 15, 2010 as Chief Operating Officer is succeeding Dr. Thomas von Rüden who advocated the change in leadership. Dr. von Rüden will continue to serve the company as an advisor.

Dr. Karl-Gerhard Seifert, chairman of the company’s advisory board commented: “After having set up the technology platform and the recent closing of the series A financing Dr. von Rüden felt that this is the right point to hand over leadership of the company to Dr. Riesmeier. Dr. Riesmeier will lead the company to the next level of becoming a product development company. Dr. von Rüden will continue to support Direvo as an advisor. The Shareholders and the Advisory Board thank Dr. von Rüden for his effort and commitment which again secured major progress and success for Direvo“.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Mouthwashes could reduce the risk of coronavirus transmission - Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses

Mouthwashes could reduce the risk of coronavirus transmission - Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses

EKF Diagnostics acquires Selah Genomics and DiaSpect Medical AB

Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect

Kiel Möbius Prize goes to renowned American microbiome researcher

Kiel Möbius Prize goes to renowned American microbiome researcher

Innovative Roche cancer medicine Avastin approved in EU - First Treatment of its Kind With Proven Survival Benefit for Patients With Advanced Colorectal Cancer

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building

Midatech secures exclusive position to exploit magnetic noble metal nanoparticles through new IP licenses - Technology has potential applications in bacterial infection and cancer

Cresset Announces New International Sales Team

Innogenetics moves into human papillomavirus (HPV) diagnostics in line with its growth strategy

SpectruMedix and Transgenomic Enter into Distribution Agreement in Europe - Complementary Genetic Analysis Platform Adds Depth to Transgenomic's Product Portfolio

Dot Products: Analytical Applications of Enzymatic Growth of Quantum Dots

Codexis and Bristol-Myers Squibb extend the term of research agreement - Codexis Achieves Milestone